The Huxley Morton Podcast

Voices from Ukraine: Clinical Research in the Aftermath of War | Ep49

In this podcast, Anna Titkova from Pratia Ukraine discusses the impact of the ongoing conflict in Ukraine on businesses and people's lives.

She shares personal stories of how she has had to adapt to the situation, including prioritizing safety, finding alternative routes home, and continuing clinical research despite the challenges.

Anna also touches on the resilience and responsibility of Ukrainian citizens in the face of adversity, with many patients in clinical trials continuing their participation despite the difficult circumstances.

Despite the initial collapse of many industries at the start of the conflict, businesses have been slowly growing and adapting to the situation.

This week's episode sheds light on the ongoing struggles faced by the people of Ukraine and their efforts to carry on amidst a challenging environment.

Revolutionizing Clinical Trials AI and Wearable Technology | Ep48

Welcome back to The Huxley Morton Podcast where we dive into the world of clinical trials and the cutting-edge technologies that are revolutionizing the industry.

In today’s episode, we speak with the CEO of Delve Health, Wessam Sonbol about his journey developing patient report outcome solutions and wearable technologies that collect data remotely.

We explore the challenges of data compliance and how they were able to utilize text messaging to significantly improve patient compliance rates.

Additionally, we discuss the impact of the pandemic on the clinical trial industry and how their technology was well-positioned to meet the needs of virtual clinical trials.

Join us as we learn about the future of clinical trials and the role of technology in advancing the field.

The Future of Healthcare: Chatbots, AI, and the Doctor’s Role in Promoting Change | Ep47

In this thought-provoking conversation, Dr. Harvey Castro discusses the potential of chatbots and AI in healthcare, and why doctors should take an active role in shaping their development.

He also addresses common misconceptions and concerns about these emerging technologies, and how they could ultimately benefit patients and healthcare professionals alike.

If you're interested in the intersection of healthcare and technology, don't miss this insightful discussion!

Uncover the Secrets of Patient Recruitment: Insights from Steve Wimmer of 1nHealth | Ep46

Welcome back to The Huxley Morton podcast where this week we delve into the fascinating world of healthcare and explore innovative solutions for improving patient outcomes.

Today, we have a special guest, Steve Wimmer, who is a seasoned professional in the field of patient recruitment for clinical trials.

Steve is currently working for 1nHealth, a company that is revolutionizing the way clinical trials are conducted. In this episode, Steve will share his journey into the industry, what motivated him to join 1nHealth, and how the company is using cutting-edge technology to deliver better results in patient recruitment.

So, sit back, relax, and join us as we delve into the exciting world of clinical trials and patient recruitment.

Helping patients get better treatment outcomes | Ep45

Does treating everyone with the same treatment create a burden on the healthcare system?

Can the requirement for Doctor appointments be cut down with data transparency?

Mark and his team at People with want to Empower the patient to effectively track and monitor their health simply so they can have better conversations and communications with their Doctors.

Find out what People with is about?

How does the app work?

How can we create efficiency to improve the health population?

Transform your drug discovery| Ep44

An antidote for the billion dollar drug problem | Ep43

Connect with Bonne Adams https://www.linkedin.com/in/bonne-adams-mba-58862417/

Get the book https://www.amazon.com/Unnecessary-Expense-Antidote-Billion-Problem/dp/1950863573/ref=sr_1_1?crid=2MET3FIPAMUD5&keywords=unnecessary+expense+Charles+theuer&qid=1669744388&sprefix=unnecessary+expense+charles+theuer%2Caps%2C177&sr=8-1

 

The drug development process in the United States is an expensive one. It costs an average of £2 billion to secure FDA approval for every new drug. So, what can we do to reduce these costs? Bonne Adams shares how Tracon Pharma https://www.traconpharma.com/ are tackling this head-on.

The next generation of Mindful Medicine | Ep42

Interested to learn more about Chris and Psilera, connect with him on LinkedIn. https://www.linkedin.com/in/cgwitowski/ .

Making small changes to the chemical structure of psychedelics to reduce hallucinations and other side effects.

This week we Speak to Co-founder and CEO Chris Witowski about the progress Psilera have made since we last spoke to them two years ago.

Helping others achieve their dreams | Ep41

Rob King https://www.linkedin.com/in/robking3/

Cro’s tend to get a bad reputation. But you can’t fault FHI Clinical a Small to Mid-sized CRO focusing on infectious disease in low-resource settings.

With a strong focus in Sub-Saharan Africa FHI has built a localized team and prides themselves on taking people with little to no experience and training them up to be the best at what they do.

This week we speak to the COO Rob King about how the skills he learnt as a Law enforcement officer working in the hostage and drug department helped him excel in the Clinical Research Industry.

Let Us Help You Take Your Clinical Trial Global |Ep40

Our guest this week is the CEO of GCP Service and President of AICROS Andreas Beust https://www.linkedin.com/in/andreas-beust-8bb32295/

 

Andreas is the face of two amazing Companies. Offering help to those trying to get into the Clinical Research industry as well as helping their clients achieve International Trial success through the AICROS network.

 

A brilliant and truly innovative way of conducting Clinical trials.